The Risk of Living Longer Series, Session 4/5: Biological Clocks

Douglas and Uli ask the ultimate question of human longevity for financial institutions: How long can we go?

If many people start achieving significantly longer lifespans, there could be far reaching effects both on society and on our financial institutions. How well is this risk of living longer really understood? People have a tendency to underestimate life expectancy, and actuaries have traditionally based future projections on historical trends. Has group think resulted in systematic blind spots in appreciating future longevity risk? Are we overlooking potential black swan events? And do we fully appreciate the differences between insured populations and the general population?

In recent years, some of the world’s top minds – and most bulging wallets – have turned their attention to various aspects of increasing both healthspan and lifespan. Snippets filter down to us through the scientific media, but the questions remain: what are the most likely avenues for progress and how close are we to significant breakthroughs in extending lives?

Douglas Anderson (Founder & Chief Visionary Officer of Club Vita) and Uli Stengele (Chief Actuary of Nationwide Financial) hosted session four of the series with Peter Joshi (Chief Scientific Officer of Humanity Inc) and John Schoonbee (Global Chief Medical Officer of Swiss Re), where they explored biological clocks to unpack these key questions:

• How can we accelerate the feedback loop of medical interventions?
• What are biomarkers? What categories do they fit into?
• What are the most indicative biomarkers?
• How accurate are they?
• How will they develop?
• What are the implications for life and health insurance?

Please click here to access the slides from this webinar.

See our Q&A document for some high-level responses to questions put to the panel that we did not have time for during the event.